A novel machine learning algorithm selects proteome signature to specifically identify cancer exosomes
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: RF selection of an exosome protein signature from published proteomic datasets and evaluation across cancer/normal datasets; linked bioRxiv preprint carries the same result. The result is limited to the reported study population and evaluation; the source does not establish transfer to other populations or improved clinical outcomes.
Technology: Random-forest selection of an exosome-protein signature
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Random-forest selection of an exosome-protein signature
- Limitation / still unknown
- The study does not establish improved patient outcomes or generalization beyond the evaluated setting.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://elifesciences.org/articles/90390.pdf · https://doi.org/10.7554/elife.90390 · https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=38529947&retmode=xml
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.